CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,399 enrolled
Drug / intervention
CEMdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03533543
NCT03533543N/ACompleted
CompareCT.gov

A Retrospective Cohort Study on the Burden of New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction at Shanghai Tenth People's Hospital

Shanghai 10th People's Hospital·observational·Posted May 23, 2018·Updated Jul 16, 2024

In Brief

An observational study evaluating CEM for Atrial Fibrillation and Myocardial Infarction. Completed, enrolled 2,399 participants across 1 site.

Detailed Summary

To characterize and estimate the incidence rate of new-onset atrial fibrillation (NOAF) in patients with acute myocardial infarction (MI). To explore the prognostic influences of NOAF on MI patients' clinical outcomes. To further investigate the impact of NOAF associated characteristics on patients' clinical outcomes eithier during hospitalization or follow-up period.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation, Myocardial Infarction
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 23, 2018
Enrollment StartMay 20, 2018
Primary CompletionJun 1, 2019
Study CompletionSep 13, 2019
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 8.1 years ago

Interventions

CEMdevice

All patients with MI hospitalized in the CCU department of Shanghai Tenth People's Hospital will receive 24-hour cardiac monitoring until discharge.